(HealthDay)—Vyvgart (efgartigimod), a neonatal Fc receptor blocker (FcRn), was approved to treat generalized myasthenia gravis in adults who test positive for the anti-acetylcholine receptor (AChR) antibody, the U.S. Food ...
Dec 21, 2021
0
6
The newest COVID-19 variant—omicron—casts a larger shadow each day, driving infection rates up just as millions of Americans prepare to travel for the upcoming holidays.
Dec 17, 2021
0
33
An intense but short-term exposure to cannabis vapor lowered sperm counts and slowed sperm movement, or motility, not only in the directly exposed male mice but also in their sons.
Dec 2, 2021
1
115
The US Food and Drug Administration on Friday approved for the first time a drug to improve growth in children with the most common type of dwarfism.
Nov 19, 2021
0
2
Even short-term exposure to air pollution impacts our brain performance and capacity to work, according to researchers from The University of Queensland and Carnegie Mellon University.
Nov 16, 2021
0
19
Women with long COVID experience heart rate irregularities in response to physical exertion, and this has the potential to constrain not only exercise tolerance but free-living physical activity.
Nov 12, 2021
0
11
New research suggests older people who were more anxious and depressed during the first year of the COVID-19 pandemic had an average decline in their short-term memory equivalent to six years of natural aging. Findings were ...
Nov 10, 2021
0
1
(HealthDay)—Patients suffering from "long COVID" can have symptoms that last a year or more, putting their jobs and everyday routines in jeopardy, a new study finds.
Oct 27, 2021
0
1
Like so many other good things in life, sleep is best in moderation. A multiyear study of older adults found that both short and long sleepers experienced greater cognitive decline than people who slept a moderate amount, ...
Oct 20, 2021
0
182
(HealthDay)—Obese people have a tougher time fighting COVID-19, even if they have a milder form of the virus, a new study finds.
Oct 20, 2021
0
23
